FTC OKs Actavis' $8B Warner Chilcott Buy With Conditions
By Jonathan Randles ( September 27, 2013, 4:53 PM EDT) -- Actavis Inc. said Friday that it has agreed to sell rights to three oral contraceptives and an osteoporosis treatment to a New Jersey-based pharmaceutical company in order to settle Federal Trade Commission charges that the drugmaker's acquisition of Ireland's Warner Chilcott PLC is anti-competitive....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.